Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)
2,485.00
+85.00 (3.54%)
At close: Jul 10, 2026
Korea Arlico Pharm Market Cap
Korea Arlico Pharm has a market cap or net worth of 38.09 billion as of July 10, 2026. Its market cap has decreased by -42.21% in one year.
Market Cap
38.09B
Enterprise Value
61.85B
Revenue
199.14B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,485.00
Market Cap Chart
Since February 12, 2018, Korea Arlico Pharm's market cap has decreased from 207.83B to 38.09B, a decrease of -81.67%. That is a compound annual growth rate of -18.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 38.09B | -41.87% |
| Dec 30, 2025 | 65.52B | 23.73% |
| Dec 30, 2024 | 52.95B | -39.39% |
| Dec 28, 2023 | 87.36B | -12.98% |
| Dec 29, 2022 | 100.39B | -14.71% |
| Dec 30, 2021 | 117.71B | -17.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Organoidsciences | 52.95B |
| Jin Yang Pharmaceutical | 49.38B |
| RP Bio | 48.10B |
| Samik Pharmaceutical Company LTD. | 42.13B |
| GeneBioTech Co. ,Ltd | 38.92B |
| Eagle Veterinary Technology Co.,Ltd | 38.49B |
| Korean Drug | 36.77B |
| HLscience | 26.53B |